A 4th dose of the bivalent or monovalent Omicron BA.1-adapted BNT162b2 vaccine elicits robust neutralizing responses in adults aged 18 to 55.

X user @Marco_Acortes and Wikimedia Commons There's no reason to believe the user was referring to COVID-19 in particular.

The 2025 Interdisciplinary Research Grant (IRG) for Convergent Innovation is designed to contribute to CUNY’s goal of amplifying the quantity and quality of engaged public impact research and ...

Problems with iron levels in the blood and the body's ability to regulate this important nutrient as a result of SARS-CoV-2 ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

The study identifies molecular changes in taste receptor cells as a potential cause of persistent taste dysfunction in long COVID-19, impacting quality of life.

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...

Coventry have been ticking along nicely again in recent weeks, following mini blips in December and January, but it looked as though the momentum might stall against Stoke. Haji Wright's sixth goal in ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was ...

International Olympic Committee (IOC) President Kirsty Coventry was caught off guard by questions about Germany and a Russian anti-doping chair, among other things, on Friday. During a press ...